Home » Clinical Trials » Therapeutic Areas

Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: Puerto Rico

Clinical Trial Details

Overview

Research Study Summary

MBB102073: A clinical research study for subjects with Diabetes Mellitus, Type 2.

Purpose

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of Dapaglifozin in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB).

Please contact us for eligibility criteria.

To Learn more

CW ID: 182100
Date Last Changed: August 12, 2013

Clinical Trial Snapshot

Phase
3
Gender
Both Male and Female
Age
N/A
Overall Status
Recruiting
Facility Type
N/A

Contact

Advanced Medical Concepts PSC
4 Baldorioty St.
Cidra 00739
Puerto Rico
Phone: 787-739-3376

Research Center Information:

Advanced Medical Concepts PSC

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.